Key Factor Supporting Portal Hypertension Management Market Development in 2025: Increasing Prevalence Of Liver Diseases Such As Hepatitis Fuels Portal Hypertension Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Portal Hypertension Management Market Size By 2025?
The market for managing portal hypertension has seen substantial growth in the past few years. The market value is expected to increase from $3.07 billion in 2024 to $3.28 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.8%. This growth during the historic period can be linked to a rise in liver diseases, an increase in the aged population, awareness and detection initiatives, the financial impact of liver diseases, approval of new drugs and therapies, and advancements in diagnostic practices.

How Big Is the Portal Hypertension Management Market Size Expected to Grow by 2029?
The market size for managing portal hypertension is projected to experience substantial growth in the upcoming years, with its value expected to reach $4.23 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.6%. This predicted surge over the forecast period can be credited to factors such as increased healthcare infrastructure investment, expanded health insurance coverage, beneficial regulations, accelerated approval procedures, and ongoing research efforts aimed at uncovering the pathophysiology of portal hypertension. New remote monitoring technologies also contribute by enabling constant patient management. Key trends that will shape the forecast period involve an increase in telemedicine use, ongoing improvements in medical technology including bio-engineered liver tissue, expansion of personalized medicine, production of targeted therapies designed for individual patient demographics, and enhanced diagnostic methods such as non-invasive imaging technologies like elastography.

View the full report here:
https://www.thebusinessresearchcompany.com/report/portal-hypertension-management-global-market-report

Which Key Market Drivers Powering Portal Hypertension Management Market Expansion and Growth?
The advancing occurrence of liver conditions such as hepatitis is anticipated to fuel the expansion of the portal hypertension management market. Liver maladies, which can affect both the liver's form and function, typically manifest symptoms like jaundice, fatigue, and stomach ache, and can be triggered by factors such as viral diseases, excessive alcohol intake, or metabolic disorders. Instances of liver diseases are on the rise due to alcohol use, viral hepatitis infections, obesity-linked fatty liver ailment, and metabolic disorders. The goal of portal hypertension management in treating liver disease is to minimize pressure in the portal vein system, mitigating complications such as variceal bleeding, ascites, and hepatic encephalopathy, hence improving patient conditions. For example, Cancer Australia, a government cancer entity based in Australia, reported in September 2022 that approximately 2,905 new incidences of liver cancer were identified in Australia in 2022 (2,113 males and 792 females). Moreover, the probability of being diagnosed with liver cancer by the age of 85 is projected to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. As such, the rising occurrence of liver illnesses is propelling the growth of the portal hypertension management market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16515&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Portal Hypertension Management Market?
Leading corporations in the portal hypertension management market are transitioning towards utilizing advanced minimally invasive tools to improve treatment results and decrease procedure-associated dangers. These minimally invasive tools are crafted for carrying out procedures with lesser disturbance to the neighboring tissues, generally done through minor incisions or natural body openings. To illustrate, Medtronic Plc, a medical device-making corporation from the US, gained the green light in November 2023 from the U.S. Food and Drug Administration (FDA) for their Symplicity Spyral renal denervation (RDN). This is a minimally invasive tool used to treat hypertension. The novelty of this procedure lies in its use of radiofrequency energy targeting nerves in the vicinity of the kidneys, effectively soothing them to manage hypertension.

What Are the Emerging Segments in the Portal Hypertension Management Market?
The portal hypertension management market covered in this report is segmented -

1) By Treatment Type: Medications, Non-Surgical Procedures, Surgery
2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Other Procedure Types
3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Medications: Beta-Blockers, Vasodilators, Diuretics, Antibiotics, Other Medications
2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL), Endoscopic Sclerotherapy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Balloon Occlusion
3) By Surgery: Liver Transplantation, Portosystemic Shunt Surgery, Surgical Decompression Of Portal Vein, Other Surgical Procedures

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16515&type=smp

Who Are the Global Leaders in the Portal Hypertension Management Market?
Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.

Which are the Top Profitable Regional Markets for the Portal Hypertension Management Industry?
North America was the largest region in the portal hypertension management market in 2023. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16515

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.